AzTrials
AzTrials

Irreversible PulpitisNCT06194773

The Effect of Totalfil and Neosealer Sealers on the Post-endodontic Pain

A study testing Totalfil, NeoSealer and AH-Plus sealer in people with Irreversible Pulpitis, run by Gulf Medical University at 1 site in United Arab Emirates.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to evaluate the effect of Totalfil and Neosealer sealers on post-endodontic pain compared to AH plus sealer in mandibular molars with symptomatic irreversible pulpitis. Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Irreversible Pulpitis
What is being tested?
Totalfil, NeoSealer and AH-Plus sealer
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
39 participants
Where
1 siteUnited Arab Emirates
Study dates
26 Jun 2023to 6 Jan 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients with mandibular molars diagnosed with symptomatic irreversible pulpitis.

Who cannot join

  • Medically compromised patients.
  • Pregnant patients.
  • Teeth with immature apex formation.

Trial locations and contacts

1 site in 1 country.

United Arab Emirates1 site
  • Gulf Medical University

    Ajman, Ajman Emirate, 4184

Other trials in United Arab Emirates

About this study

Official title: Evaluation of the Effect of Totalfil and Neosealer Sealers on the Post-endodontic Pain in Mandibular Molars Diagnosed With Symptomatic Irreversible Pulpitis; a Randomized Control Study.

The goal of this clinical trial is to evaluate the effect of Totalfil and Neosealer sealers on post-endodontic pain compared to AH plus sealer in mandibular molars with symptomatic irreversible pulpitis. The main question: do Totalfil and Neosealer sealers affect postoperative pain intensity after root canal treatment in mandibular molars with symptomatic irreversible pulpitis? Participants will undergo root canal treatment using totalfil, Neosealer, or AH-Plus sealer. Researchers will compare Totalfil, Neosealer, and AH-Plus to assess the intensity of post-endodontic pain.

Read the detailed description

The study will be conducted on 39 mandibular molars; with 13 mandibular mandibular molars in each group (n=13). The patient will be asked to pick an opaque sealed envelope that will contain a number from 1 to 3. The resultant number will determine in which group the participants will be placed. Double blinding will be maintained in this study as the assessor and the patients will not be aware of their group/used root canal sealer.

Group I: Endodontic treatment with obturation using single cone technique with Totalfil sealer.

Group 2: Endodontic treatment with obturation using single cone technique with Neosealer.

Group 3: Endodontic treatment with obturation using single cone technique with AH plus sealer.

Clinical procedure:

  1. Patient history will be recorded before starting the procedure.
  2. The consent form will be given and signed by the patient.
  3. Pre-operative pain will be assessed using VAS.
  4. Tooth diagnosis will take place through visualization, percussion, palpation, mobility, electric pulp test as well as cold test before the treatment begins.
  5. Pre-operative radiograph will be taken to confirm diagnosis.
  6. All the patients will receive local anesthesia: 2% lidocaine with 1:100,000 epinephrine. The inferior alveolar nerve block will be administered.
  7. A single tooth will be isolated using a rubber dam, and the access cavity will be prepared using a round bur (no.4) and tapered fissure diamond stone (NO173).
  8. The saliva ejector will be introduced below the integrated frame and will be positioned in the corner of the mouth.
  9. De-roofing of the pulp chamber will be done using Endo Z bur.
  10. After removal of the pulp tissue using an H-file, the working length will be determined with stainless steel hand K-files size #10 and the use of an apex locator and confirmed using intraoral periapical radiographs.
  11. All the canals will be prepared using Protaper Gold rotary system using NSK endodontic motor, according to the manufacturer guidelines.
  12. To establish apical patency between the files during shaping we will use initial file size #10 between each instrument.
  13. Each canal will be irrigated with 30 mL 3% NaOCl and flushed with saline 10 mL between each file during the whole preparation procedure using a plastic syringe with a side vented needle.
  14. After completion of cleaning and shaping in all the canals will be flushed with a final rinse of NaOCl, saline and EDTA 17%.
  15. For group 1, the canals will be moist and obturated using the single cone technique by gutta percha using Totalfill as a sealer.
  16. For group 2, the canals will be moist and obturated using the single cone technique by gutta percha using Neosealer.
  17. For group 3, the canals will be dried using suitable size of paper points, followed by obturation using single cone technique using AH plus as a sealer.
  18. Final restoration will be placed.
  19. Post-operative pain will be accessed using The Visual Analogue Scale (VAS), after 6, 24, 48, 72 hours, and 7 days. Any analgesic pills taken by the patient will be reported.
Being tested
Totalfil, NeoSealer, AH-Plus sealer

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TotalfilProcedure or surgery

    Root canal treatment using TotalFil sealer

  • NeoSealerProcedure or surgery

    Root canal treatment using NeoSealer

  • AH-Plus sealerProcedure or surgery

    Root canal treatment using AH-Plus sealer

Study groups in NCT06194773
Study groupRoleWhat they receive
TotalfilExperimentalNot described
Receives: Procedure: Totalfil
NeoSealerExperimentalNot described
Receives: Procedure: NeoSealer
AH-PlusActive comparatorNot described
Receives: Procedure: AH-Plus sealer

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The level of post-endodontic pain

    Evaluation of the pain intensity using the Visual Analogue Scale. The Visual Analogue Scale measures pain intensity. The Visual Analogue Scale consists of a 10 cm with two endpoints representing 0 ('no pain') and 10 ('pain as bad as it could be)

    Measured: 6 hours

  2. The level of post-endodontic pain

    Evaluation of the pain intensity using the Visual Analogue Scale. The Visual Analogue Scale measures pain intensity. The Visual Analogue Scale consists of a 10 cm with two endpoints representing 0 ('no pain') and 10 ('pain as bad as it could be)

    Measured: 24 hours

  3. The level of post-endodontic pain

    Evaluation of the pain intensity using the Visual Analogue Scale. The Visual Analogue Scale measures pain intensity. The Visual Analogue Scale consists of a 10 cm with two endpoints representing 0 ('no pain') and 10 ('pain as bad as it could be)

    Measured: 48 hours

  4. The level of post-endodontic pain

    Evaluation of the pain intensity using the Visual Analogue Scale. The Visual Analogue Scale measures pain intensity. The Visual Analogue Scale consists of a 10 cm with two endpoints representing 0 ('no pain') and 10 ('pain as bad as it could be)

    Measured: 72 hours

  5. The level of post-endodontic pain

    Evaluation of the pain intensity using the Visual Analogue Scale. The Visual Analogue Scale measures pain intensity. The Visual Analogue Scale consists of a 10 cm with two endpoints representing 0 ('no pain') and 10 ('pain as bad as it could be)

    Measured: 7 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jan 2024
  2. Study start26 Jun 2023
  3. Primary completion6 Dec 2024
  4. Study completion6 Jan 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
39 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06194773
Sponsor's protocol ID
IRB-COD-STD-123-JUNE-2023
Status last verified
Mar 2025
First submitted
22 Dec 2023
Last updated
14 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Totalfil, NeoSealer and AH-Plus sealer in people with Irreversible Pulpitis, run by Gulf Medical University at 1 site in United Arab Emirates.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Arab Emirates. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The level of post-endodontic pain (time frame: 6 hours). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in